Institutional Cluster

APGE

Apogee Therapeutics, Inc.
MIXED
Impact 5/10
Horizonweeks Processed1mo ago
Institutional cluster: 4 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The Citigroup mega-buy ($37.2M increase) is a high-conviction signal from a sophisticated active manager, but it is offset by two near-full exits from Jennison ($48.3M) and Pictet ($21.1M) plus a full exit from Aberdeen ($12.1M). The lack of insider buying weakens the bullish thesis. Monitor upcoming pipeline catalysts and Q3 13F filings to see whether Citigroup's conviction was prescient or the sellers were right to reduce. The 100% historical win rate on APGE reports suggests the stock has strong momentum, but this cluster's mixed signal warrants caution.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d
APGE ▲ +0.43% at T+20d
NEUTRAL call ✓ call won +0.43% · α vs SPY -0.17% · entry $134.49 → $135.07
Next anchor: T+60d in 28d
Entry anchored
Aug 6, 2026
via day open
T+1d
+0.26%
call +0.26% · α -0.35%
$134.84
settled 8w ago
T+5d
-0.03%
call -0.03% · α -1.24%
$134.45
settled 7w ago
T+20d
+0.43%
call +0.43% · α -0.17%
$135.07
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Executive Summary

Apogee Therapeutics (APGE) saw a mixed institutional cluster in Q2 2026: 4 buyers added $42.8M in new holdings (led by Citigroup's massive $37.2M increase), while 5 sellers reduced positions by $94.4M (led by Jennison Associates' $48.3M near-exit and Aberdeen Group's full $12.1M exit). The divergence is stark — Citigroup's conviction buy (nearly 20x position) contrasts with two major asset managers exiting almost entirely. The cluster is dominated by active managers on both sides, suggesting a fundamental disagreement on valuation or pipeline prospects rather than passive rebalancing. With no insider buying to corroborate the accumulation side, the net signal is ambiguous despite the large dollar amounts involved.

Key Financial Metrics

Direction
mixed
Buy Value
$48.4M
Sell Value
$94.4M
Net Flow
-$51.6M

Institutional Positions

Net institutional flow: -$51.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
CitigroupDOUBLED+1969.4%$38.4M$37.2M
Alps AdvisorsADD+37.2%$8.3M$4.5M
Strs OhioADD+93.2%$1.1M$758.0K
Envestnet Asset ManagementADD+28.6%$597.0K$303.0K

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Jennison AssociatesNEAR_EXIT-98.8%$49.2M-$48.3M
Pictet Asset Management HoldingNEAR_EXIT-97.5%$22.0M-$21.1M
Td Asset ManagementNEAR_EXIT-88.9%$15.6M-$12.8M
Aberdeen GroupEXIT-100%$12.1M-$12.1M
New York State Common Retirement FundTRIM-38.8%$2.2M-$77.3K

Key Facts

  • 4 institutional buyers added $42.8M in new APGE holdings in Q2 2026
  • 5 institutional sellers reduced positions by $94.4M in the same quarter
  • Citigroup DOUBLED its position by 1,969% to $38.4M, the largest single move
  • Jennison Associates NEAR-EXITED, selling 98.8% of its $49.2M stake
  • Aberdeen Group fully EXITED a $12.1M position
  • No open-market insider buying to support the accumulation side
  • Net institutional flow was negative: $94.4M sold vs $42.8M bought

Financial Impact

4 institutional buyers added $42.8M in new positions while 5 sellers reduced holdings by $94.4M, for a net institutional outflow of approximately $51.6M

institutional ownershipfloat

Risk Factors

  • The 45-day 13F reporting lag means positions may have already been unwound or added to since quarter-end
  • Net institutional outflow of ~$51.6M suggests more capital exited than entered
  • No insider buying to corroborate the accumulation thesis
  • Two major asset managers (Jennison, Pictet) nearly fully exited, signaling potential fundamental concerns

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
33% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-APGE-2026-Q2
31 reports for APGE
Performance horizon
93% Hit rate 14 of 15 directional calls best @ T+60▲ +73.31%May 27, 2026
Filters
Rows
Reports for APGE — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
15-12G
NEUTRAL ★ 4/10
—awaiting T+5——
Sep 3, 2026
29d ago
25-NSE
BULLISH ★ 8/10
$135.06 awaiting T+5awaiting T+5——
Sep 3, 2026
29d ago
8-K
BULLISH ★ 8/10
$135.06 awaiting T+5awaiting T+5——
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$134.55 $134.71▲ +0.12%▲ +0.56%—
Aug 10, 2026
7w ago
8-K
BULLISH ★ 8/10
$134.65 $134.59▼ −0.04%▲ +0.00%—
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 8/10
$134.65 $134.59▼ −0.04%▲ +0.00%—
Aug 6, 2026
8w ago
Institutional Cluster
MIXED ★ 5/10
$134.49 $134.45▼ −0.03%▼ −1.24%—
Aug 3, 2026
8w ago
DEFA14A
BULLISH ★ 5/10
$134.19 $134.69▲ +0.37%▲ +0.47%—
Jul 11, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$133.82 $134.00▲ +0.13%▲ +0.92%—
Jun 26, 2026
13w ago
DEFA14A
BULLISH ★ 6/10
$132.61 $133.50▲ +0.67%▼ −0.72%—
Showing 10 of 31

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 6, 2026